These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28207831)
1. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics. Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831 [TBL] [Abstract][Full Text] [Related]
2. The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA). Niu H; Yang J; Yang K; Huang Y Medicine (Baltimore); 2017 Nov; 96(46):e8630. PubMed ID: 29145283 [TBL] [Abstract][Full Text] [Related]
3. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis. Yang J; Niu H; Huang Y; Yang K PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114 [TBL] [Abstract][Full Text] [Related]
4. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis. Huang YZ; Wu W; Wu K; Xu XN; Tang WR Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469 [TBL] [Abstract][Full Text] [Related]
5. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Shi DT; Han M; Gao N; Tian W; Chen W Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879 [TBL] [Abstract][Full Text] [Related]
6. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171 [TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA). Zhan L; Zhang B; Tan Y; Yang C; Huang C; Wu Q; Zhang Y; Chen X; Zhou M; Shu A Medicine (Baltimore); 2017 Feb; 96(7):e6097. PubMed ID: 28207521 [TBL] [Abstract][Full Text] [Related]
8. Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis. Huang YQ; Guan H; Liu CH; Liu DC; Xu B; Jiang L; Lin ZX; Chen M Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173228 [TBL] [Abstract][Full Text] [Related]
9. The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. Jiang Y; Cui L; Chen WD; Shen SH; Ding LD PLoS One; 2012; 7(5):e36780. PubMed ID: 22615811 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies. Wang HL; Liu P; Zhou PY; Zhang Y Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386 [TBL] [Abstract][Full Text] [Related]
11. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis. Hu F; Chen L; Bi MY; Zheng L; He JX; Huang YZ; Zhang Y; Zhang XL; Guo Q; Luo Y; Tang WR; Sheng MM Pathol Res Pract; 2020 Aug; 216(8):153009. PubMed ID: 32703486 [TBL] [Abstract][Full Text] [Related]
12. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis. Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374 [TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer]. Wei H; Fang N; Guo L; Wu Z; Zhou Q Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870 [TBL] [Abstract][Full Text] [Related]
14. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis. Guo Y; Long J; Lei S J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527 [TBL] [Abstract][Full Text] [Related]
15. Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis. Yang JZ; Ji AF; Wang JS; Chen ZY; Wen SW Asian Pac J Cancer Prev; 2014; 15(9):3921-5. PubMed ID: 24935575 [TBL] [Abstract][Full Text] [Related]
16. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis. Si JG; Su YY; Han YH; Chen RH Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911 [TBL] [Abstract][Full Text] [Related]
17. The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Ge YZ; Xu LW; Jia RP; Xu Z; Feng YM; Wu R; Yu P; Zhao Y; Gui ZL; Tan SJ; Song Q Tumour Biol; 2014 Apr; 35(4):3881-90. PubMed ID: 24353088 [TBL] [Abstract][Full Text] [Related]
18. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis. Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306 [TBL] [Abstract][Full Text] [Related]
19. Association Between Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis. Wang J; Wang B; Chen X; Bi J Carcinogenesis; 2011 Mar; 32(3):411-6. PubMed ID: 21156971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]